Molecular Oncology, Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.
Clin Pharmacol Ther. 2010 Jun;87(6):633-5. doi: 10.1038/clpt.2010.47.
The use of genetic information to design and guide therapies creates novel patent issues. Gene patents have been integral to the introduction of new biologics, but their role in diagnostic testing is controversial. Genotype-phenotype associations are at the heart of personalized medicine. The intellectual property rules by which these biological relationships are governed have profound implications for the growth of this field. Several cases currently before the courts may add reason and clarity to the law in this area.
利用遗传信息设计和指导治疗方法会产生新的专利问题。基因专利对于新型生物制剂的问世不可或缺,但它们在诊断测试中的作用却颇具争议。基因型-表型相关性是个性化医疗的核心。管理这些生物学关系的知识产权规则对该领域的发展具有深远的影响。目前法院审理的几个案件可能会为该领域的法律提供更多的依据和明确性。